Progressive Transformation of Germinal Centers

Replaced "Progressive Transformation Of Germinal Centers" with "Progressive Transformation of Germinal Centers".

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Hodgkin Disease (Hodgkin's Disease)
2.	B-Cell Lymphoma (Lymphoma, B Cell)
3.	Lymphoma (Lymphomas)
4.	Hyperplasia
5.	Pathologic Complete Response

Experts

1.	Abukhiran, Ibrahim: 1 article (08/2021)
2.	Holman, Carol J: 1 article (08/2021)
3.	Syrbu, Sergei I: 1 article (08/2021)
4.	Ciancia, Giuseppe: 1 article (11/2011)
5.	Fabbricini, Rossella: 1 article (11/2011)
6.	Grimaldi, Francesco: 1 article (11/2011)
7.	Mainolfi, Ciro: 1 article (11/2011)
8.	Pane, Fabro: 1 article (11/2011)
9.	Pettinato, Guido: 1 article (11/2011)
10.	Picardi, Marco: 1 article (11/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Progressive Transformation of Germinal Centers:

1.	Inducible T-Cell Co-Stimulator ProteinIBA 08/04/2021 - "We performed programmed death-1 (PD-1), C-X-C motif chemokine ligand 13 (CXCL13), inducible costimulator (ICOS), CD10, and B-cell lymphoma 6 protein (BCL-6) immunohistochemistry on AITL, PTCL not otherwise specified (PTCL-NOS), PTCL-TFH, T-cell or histiocyte-rich large B-cell lymphoma (THRLBCL), classic Hodgkin lymphoma (CHL), atypical paracortical hyperplasia (PCH), progressive transformation of germinal centers (PTGC), and reactive follicular hyperplasia (RFH). "
2.	Proto-Oncogene Proteins c-bcl-6IBA 08/04/2021 - "We performed programmed death-1 (PD-1), C-X-C motif chemokine ligand 13 (CXCL13), inducible costimulator (ICOS), CD10, and B-cell lymphoma 6 protein (BCL-6) immunohistochemistry on AITL, PTCL not otherwise specified (PTCL-NOS), PTCL-TFH, T-cell or histiocyte-rich large B-cell lymphoma (THRLBCL), classic Hodgkin lymphoma (CHL), atypical paracortical hyperplasia (PCH), progressive transformation of germinal centers (PTGC), and reactive follicular hyperplasia (RFH). "
3.	ChemokinesIBA 08/04/2021 - "We performed programmed death-1 (PD-1), C-X-C motif chemokine ligand 13 (CXCL13), inducible costimulator (ICOS), CD10, and B-cell lymphoma 6 protein (BCL-6) immunohistochemistry on AITL, PTCL not otherwise specified (PTCL-NOS), PTCL-TFH, T-cell or histiocyte-rich large B-cell lymphoma (THRLBCL), classic Hodgkin lymphoma (CHL), atypical paracortical hyperplasia (PCH), progressive transformation of germinal centers (PTGC), and reactive follicular hyperplasia (RFH). "
4.	ParaffinIBA 09/01/2003 - "We studied mantle B-cell and T-cell ingression in hyperplastic follicles (HFs), follicular lysis (FL), and progressive transformation of germinal centers (PTGC) in 19 paraffin-embedded, H&E-, bcl-2-, CD20-, and CD3-stained lymph nodes. "
5.	LigandsIBA 08/04/2021 - "We performed programmed death-1 (PD-1), C-X-C motif chemokine ligand 13 (CXCL13), inducible costimulator (ICOS), CD10, and B-cell lymphoma 6 protein (BCL-6) immunohistochemistry on AITL, PTCL not otherwise specified (PTCL-NOS), PTCL-TFH, T-cell or histiocyte-rich large B-cell lymphoma (THRLBCL), classic Hodgkin lymphoma (CHL), atypical paracortical hyperplasia (PCH), progressive transformation of germinal centers (PTGC), and reactive follicular hyperplasia (RFH). "
6.	Rituximab (Mabthera)FDA Link 11/01/2011 - "Because the lymphatic tissue of progressive transformation of germinal centers (PTGC) expresses CD20, rituximab treatment may prevent transformation to lymphoma of this rather atypical entity. " 11/01/2011 - "Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy."

Therapies and Procedures

1.	Induction Chemotherapy 11/01/2011 - "Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy."
2.	Radiotherapy 11/01/2011 - "Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy."